Levesam XR 500mg Eazy Glide Tablet contains Levetiracetam 500mg, an antiepileptic medication indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and preventing seizure propagation. The extended-release formulation allows for once-daily dosing, improving patient compliance and maintaining steady plasma drug concentrations. Levesam XR is indicated as adjunctive therapy in adults and pediatric patients aged four years and older. The Eazy Glide coating facilitates ease of swallowing, enhancing patient adherence. Common adverse effects include somnolence, dizziness, headache, and fatigue, which are generally mild to moderate and transient. Caution is advised in patients with renal impairment, as dosage adjustment may be necessary. Levesam XR should be used under strict medical supervision, with regular monitoring for efficacy and tolerability. Abrupt discontinuation should be avoided to reduce the risk of increased seizure frequency. This medication is contraindicated in patients with known hypersensitivity to Levetiracetam or any of the tablet excipients. Levesam XR 500mg Eazy Glide Tablet offers a convenient and effective option for long-term seizure management.